Afasevikumab Biosimilar - Research Grade

Human

IL17Aï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q16552

Blue ice

Interleukin-17A (IL17A) is a pro-inflammatory Th17 cytokine that orchestrates tissue inflammation and is a key target in autoimmune disease research. Offered as an unconjugated, non-therapeutic analog of afasevikumab, this research-grade anti-human IL17A recombinant monoclonal antibody is intended for research use only (RUO). It is manufactured to demanding in vivo standards, formulated for low endotoxin, and supplied in scalable milligram (mg) to gram (g) quantities for high-throughput and heavy-usage laboratories. Typical uses include cytokine neutralization assays, in vitro functional screening, and in vivo models of autoimmune and inflammatory disease requiring a reproducible reagent.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks